» Articles » PMID: 18672286

Increased Susceptibility of Complement Factor B/C2 Double Knockout Mice and Mannan-binding Lectin Knockout Mice to Systemic Infection with Candida Albicans

Overview
Journal Mol Immunol
Date 2008 Aug 2
PMID 18672286
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Candida albicans is the major cause of systemic fungal infections in immunocompromised patients. We investigated the susceptibility of mice deficient in complement factor B and C2 (Bf/C2-/-), C1q (C1qa-/-), and mannan-binding lectin (MBL)-A (MBL-A) and MBL-C (MBL-A/C-/-) to systemic infection with C. albicans. Animals were infected i.p. with 10(8)C. albicans blastoconidia and monitored for mortality. Bf/C2-/- mice showed high mortality (over 90%) within the study period of 3 weeks. In contrast, mortality in C1qa-/- mice was below 15% whereas that of MBL-A/C-/- mice was 40% (P<0.001). Intravenous infection of mice with 8x10(5) blastoconidia resulted in the same trend with Bf/C2-/- mice being highly susceptible compared to the other strains. Histology of kidney sections of infected Bf/C2-/- mice showed widespread mycelia confirming the high CFU counts from cultured tissue homogenates. In C1qa-/-, MBL-A/C-/- and wild type C57BL/6 mice hyphal growth was limited. However, massive inflammatory infiltration was apparent, which was not seen in Bf/C2-/- mice. The ability of the mouse sera to opsonize C. albicans was determined by quantification of phagocytosis of C. albicans by peritoneal phagocytes. Whilst phagocytosis mediated by Bf/C2-/- mouse serum was low (10.6%), more phagocytosis could be seen in MBL-A/C-/- (19.9%), C1qa-/- mice (23.9%) and wild type mice (29%). Deficiency of classical pathway activation has only a low impact whereas the lectin pathway contributes to the host defence against candidosis. The more pronounced lack of complement activation in Bf/C2-/- mice leads to uncontrolled infection due to an opsonophagocytic defect.

Citing Articles

and : global priority pathogens.

Katsipoulaki M, Stappers M, Malavia-Jones D, Brunke S, Hube B, Gow N Microbiol Mol Biol Rev. 2024; 88(2):e0002123.

PMID: 38832801 PMC: 11332356. DOI: 10.1128/mmbr.00021-23.


Complement factor B is essential for the proper function of the peripheral auditory system.

Brown L, Barth J, Jafri S, Rumschlag J, Jenkins T, Atkinson C Front Neurol. 2023; 14:1214408.

PMID: 37560455 PMC: 10408708. DOI: 10.3389/fneur.2023.1214408.


Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation.

Liu T, Zhuang X, Juan Qin X, Bing Wei L, Rong Gao J Front Pharmacol. 2023; 13:1069810.

PMID: 36642989 PMC: 9838551. DOI: 10.3389/fphar.2022.1069810.


Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organ-protective phenotype in trauma.

Yang Z, Nunn M, Le T, Simovic M, Edsall P, Liu B Br J Pharmacol. 2022; 180(4):422-440.

PMID: 36251578 PMC: 10100417. DOI: 10.1111/bph.15970.


C1q as a target molecule to treat human disease: What do mouse studies teach us?.

Schulz K, Trendelenburg M Front Immunol. 2022; 13:958273.

PMID: 35990646 PMC: 9385197. DOI: 10.3389/fimmu.2022.958273.